Knowing prior methicillin-resistant Staphylococcus aureus (MRSA) infection or colonization status increases the empirical use of glycopeptides in MRSA bacteraemia and may decrease mortality.

Knowing prior methicillin-resistant Staphylococcus aureus (MRSA) infection or colonization status increases the empirical use of glycopeptides in MRSA bacteraemia and may decrease mortality.

To compare the management and outcome of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in patients known to be MRSA-colonized/infected (C-patients) with the management and outcome in those not known to be colonized/infected (NC-patients), we conducted a 10-year retrospective review...

Full description

Bibliographic Details
Main Authors: Phillips, M., Robinson, J., Christiansen, Keryn, Pearson, J., Coombs, Geoffrey, Murray, R.
Format: Journal Article
Published: Blackwell Publishing 2013
Subjects:
methicillin-resistant Staphylococcus aureus
mortality
Staphylococcus aureus
Bacteraemia
colonization
Online Access:http://hdl.handle.net/20.500.11937/27044

Internet

http://hdl.handle.net/20.500.11937/27044

Similar Items